Notably, the HDAC7 inhibitor MC1568 was reported to protect β-cells from dysfunction and death, suggesting that specific inhibitors for HDAC7 may be useful for T2D treatment (79). Here, HDAC7 is linked to type 2 diabetes mellitus.